The average P/S ratio for WGS's competitors is 2.12, providing a benchmark for relative valuation. GeneDx Holdings Corp Corp (WGS) exhibits a P/S ratio of 6.88, which is 225.05% above the industry average. Given its robust revenue growth of 39.56%, this premium appears sustainable.